RASGRF2 and gastric adenocarcinoma: To investigate potential molecular mechanisms underlying the association between RASGRF2 expression and STAD, GO term and biological pathway enrichment analysis as well as GSEA were conducted, using as inputs the list of genes significantly differentially expressed in patients with STAD exhibiting high RASGRF2 transcript levels (and gene expression levels, in the case of GSEA).